DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
Clinical trial NCT06539182 · RECRUITING
Trial details
- NCT number
- NCT06539182
- Sponsor
- Dizal Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-29
- Primary completion
- 2027-09-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.